Related Experiment Videos
Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis
S Lindemann1, N D Tolley, D A Dixon
1Department of Internal Medicine, University of Utah, Salt Lake City, UT 84112, USA.
The Journal of Cell Biology
|August 8, 2001
Summary
Platelets, traditionally known for clotting, can synthesize and release interleukin-1beta (IL-1beta), a key inflammatory cytokine. This discovery reveals new roles for platelets in inflammation and suggests potential anti-inflammatory benefits of antithrombotic drugs.
Area of Science:
- Immunology
- Hematology
- Molecular Biology
Background:
- Platelets are anucleate cells primarily involved in hemostasis and acute inflammation.
- They were not previously known to synthesize proteins or cytokines or to modulate chronic inflammatory responses.
Purpose of the Study:
- To investigate the potential for protein synthesis in quiescent and activated platelets.
- To explore the role of platelets in sustained inflammatory responses and vascular injury.
Main Methods:
- cDNA library screening to identify platelet transcripts.
- Analysis of messenger RNA (mRNA) localization on polysomes.
- Assessment of pro-interleukin-1beta (pro-IL-1beta) synthesis upon platelet activation.
- Measurement of mature IL-1beta release in microvesicles.
- Evaluation of endothelial cell adhesiveness for neutrophils.
- Investigation of the role of beta3 integrin signaling in IL-1beta synthesis.
Main Results:
- Quiescent platelets contain mRNA for pro-IL-1beta and other transcripts, present on polysomes for rapid synthesis.
- Platelet activation triggers rapid and sustained synthesis of pro-IL-1beta.
- Mature IL-1beta is released in microvesicles, increasing endothelial cell adhesiveness for neutrophils.
- Beta3 integrin engagement is critical for IL-1beta synthesis, linking coagulation and inflammation.
Conclusions:
- Platelets possess a previously unrecognized capacity for de novo synthesis of active cytokines like IL-1beta.
- Platelet-derived IL-1beta contributes to endothelial cell activation and neutrophil recruitment, implicating platelets in sustained inflammation and vascular injury.
- Targeting beta3 integrin may offer novel anti-inflammatory effects, suggesting potential dual benefits for antithrombotic therapies.